Price T Rowe Associates Inc Zoetis Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,836,353 shares of ZTS stock, worth $289 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,836,353
Previous 4,126,021
55.49%
Holding current value
$289 Million
Previous $806 Million
62.89%
% of portfolio
0.03%
Previous 0.09%
Shares
17 transactions
Others Institutions Holding ZTS
# of Institutions
2,051Shares Held
419MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.51 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.8 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.12 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.52 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.86 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $73.7B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...